Carter L. Myers

1.4k total citations
8 papers, 1.1k citations indexed

About

Carter L. Myers is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Carter L. Myers has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 2 papers in Microbiology. Recurrent topics in Carter L. Myers's work include Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (6 papers) and Parasitic Diseases Research and Treatment (1 paper). Carter L. Myers is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (6 papers) and Parasitic Diseases Research and Treatment (1 paper). Carter L. Myers collaborates with scholars based in United States, Canada and Spain. Carter L. Myers's co-authors include Scott G. Filler, John E. Edwards, Quynh T. Phan, Ashraf S. Ibrahim, Donald C. Sheppard, Michael R. Yeaman, Yue Fu, William H. Welch, Hyun‐Sook Park and Aaron P. Mitchell and has published in prestigious journals such as PLoS Biology, The Journal of Infectious Diseases and Infection and Immunity.

In The Last Decade

Carter L. Myers

8 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carter L. Myers United States 8 928 669 311 129 119 8 1.1k
Antje Albrecht Germany 10 912 1.0× 619 0.9× 428 1.4× 176 1.4× 192 1.6× 10 1.2k
Lydia Schild Germany 9 648 0.7× 462 0.7× 236 0.8× 101 0.8× 132 1.1× 10 913
Jonathan S. Finkel United States 10 601 0.6× 483 0.7× 453 1.5× 108 0.8× 93 0.8× 13 1.0k
Soon-Hwan Oh United States 14 890 1.0× 603 0.9× 343 1.1× 157 1.2× 165 1.4× 16 1.1k
Marc Swidergall United States 21 902 1.0× 578 0.9× 334 1.1× 134 1.0× 96 0.8× 31 1.3k
M A Ghannoum United States 15 869 0.9× 772 1.2× 156 0.5× 84 0.7× 74 0.6× 15 1.2k
Ronny Martin Germany 21 844 0.9× 583 0.9× 524 1.7× 147 1.1× 101 0.8× 33 1.2k
Fabien Cottier Singapore 21 626 0.7× 379 0.6× 563 1.8× 165 1.3× 66 0.6× 21 1.1k
Elisabetta Spreghini Italy 20 802 0.9× 621 0.9× 241 0.8× 73 0.6× 65 0.5× 36 1.1k
Quinn M. Mitrovich United States 8 666 0.7× 434 0.6× 623 2.0× 151 1.2× 64 0.5× 8 1.1k

Countries citing papers authored by Carter L. Myers

Since Specialization
Citations

This map shows the geographic impact of Carter L. Myers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carter L. Myers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carter L. Myers more than expected).

Fields of papers citing papers by Carter L. Myers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carter L. Myers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carter L. Myers. The network helps show where Carter L. Myers may publish in the future.

Co-authorship network of co-authors of Carter L. Myers

This figure shows the co-authorship network connecting the top 25 collaborators of Carter L. Myers. A scholar is included among the top collaborators of Carter L. Myers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carter L. Myers. Carter L. Myers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Nobile, Clarissa J., Norma V. Solis, Carter L. Myers, et al.. (2008). Candida albicanstranscription factor Rim101 mediates pathogenic interactions through cell wall functions. Cellular Microbiology. 10(11). 2180–2196. 120 indexed citations
2.
Phan, Quynh T., Carter L. Myers, Yue Fu, et al.. (2007). Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells. PLoS Biology. 5(3). e64–e64. 464 indexed citations
3.
Spellberg, Brad, Ashraf S. Ibrahim, Valentina Avanesian, et al.. (2006). Efficacy of the Anti‐CandidarAls3p‐N or rAls1p‐N Vaccines against Disseminated and Mucosal Candidiasis. The Journal of Infectious Diseases. 194(2). 256–260. 144 indexed citations
4.
Martínez‐López, Raquel, Hyun‐Sook Park, Carter L. Myers, Concha Gil, & Scott G. Filler. (2006). Candida albicans Ecm33p Is Important for Normal Cell Wall Architecture and Interactions with Host Cells. Eukaryotic Cell. 5(1). 140–147. 63 indexed citations
5.
Spellberg, Brad, Ashraf S. Ibrahim, Scott G. Filler, et al.. (2005). The Anti- Candida albicans Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice. Infection and Immunity. 73(9). 6191–6193. 64 indexed citations
6.
Park, Hyun‐Sook, Carter L. Myers, Donald C. Sheppard, et al.. (2004). Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cellular Microbiology. 7(4). 499–510. 163 indexed citations
7.
Myers, Carter L., et al.. (2003). Endothelial contraction and monolayer hyperpermeability are regulated by Src kinase. American Journal of Physiology-Heart and Circulatory Physiology. 284(3). H994–H1002. 26 indexed citations
8.
Johnston, Douglas A., et al.. (2003). Relationship between Candida albicans Virulence during Experimental Hematogenously Disseminated Infection and Endothelial Cell Damage In Vitro. Infection and Immunity. 72(1). 598–601. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026